Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
03/2008
03/05/2008CN101134758A Method for extracting and separating bilobalide A, B, C, J and bilobalide monomer from ginkgo leaf
03/04/2008US7339014 A copolymer comprising (meth)acrylated 8 or 9-methacryloyloxy-4-oxatricyclo[5.2.1.02,6]decane-3-one monomer; chemically amplified photoresist composition comprising photoacid generator; transparency to ultraviolet light, solubility in solvents; photolithography; not from Diels-Alder reaction
02/2008
02/28/2008WO2008023828A1 Chromene compound
02/28/2008WO2008022725A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral disorders
02/28/2008WO2008022462A1 Para-quinol derivatives and methods of stereo selectively synthesizing and using same
02/28/2008WO2007025043A3 Seven-membered ring nucleosides
02/28/2008US20080051446 Heterocyclocarboxamide Derivatives
02/28/2008US20080051407 These compounds lack a 1,4-bridging group as found in the ecteinascidins; and, have at the C-1 position a substituent selected from an amino or hydroxy group, optionally protected or derivatized; anticarcinogenic agents
02/28/2008CA2661401A1 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
02/28/2008CA2660084A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseases
02/27/2008EP1891005A2 Process for preparation of 13,14-dihydro-pgf2 alpha derivatives
02/27/2008CN101133022A Substituted 2-pyrrolidone derivatives as fungicides and insecticides
02/27/2008CN101130548A Method for extracting and producing high content arteannuin
02/27/2008CN101130547A Method for removing methylene of gingili wood phenols
02/27/2008CN101130528A Process for the preparation of baccatin iii derivatives
02/26/2008US7335775 Effector conjugates, process for their production and their pharmaceutical use
02/26/2008US7335632 Selectively inhibit memapsin 2 beta -secretase activity relative to memapsin 1 beta -secretase activity; Alzheimer's disease
02/21/2008WO2008021213A1 Macrocyclic compounds useful as inhibitors of kinases and hsp90
02/21/2008WO2008019820A2 Crystal form of epothilone b and use in pharmaceutical compositions
02/21/2008CA2696021A1 Macrocyclic compounds useful as inhibitors of kinases and hsp90
02/21/2008CA2658475A1 Organic compounds
02/20/2008EP1889845A1 Novel pleuromutilin derivatives
02/20/2008EP1889826A1 Method for producing hexahydrofurofuranol derivative
02/20/2008EP1888707A1 New materials for organic electroluminescence devices
02/20/2008EP1888564A2 Benzofuran compounds
02/20/2008EP1888546A1 Thiazole derivatives and use thereof
02/20/2008CN101128469A 蛋白酶抑制剂前体的合成 Synthetic precursor protease inhibitors
02/20/2008CN100369917C Himbacine analogues as thrombin receptor antagonists
02/20/2008CN100369904C 2-(replace- amino)-NOBS HIV prolease inhibitor
02/19/2008CA2287557C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
02/19/2008CA2287556C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
02/14/2008WO2007149305A3 Improved oxidation process with enhanced safety useful in the manufacture of moxidectin by means of stabilised 2-iodoxybenzoic acid (sibx)
02/14/2008US20080039520 Anti-first-pass effect compounds
02/14/2008US20080039486 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies
02/14/2008US20080039442 Compounds With Kv4 Ion Channel Activity
02/13/2008EP1885728A1 Conversion of amorpha-4,11- diene to artemisinin and artemisinin precursors
02/13/2008EP1885715A1 Selected tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
02/13/2008CN101124230A Process for preparing forms of atorvastatin calcium substantially free of impurities
02/13/2008CN101124190A Process for the preparation of cis-2-acetyl-1, 2, 3, 4, 5, 6, 7, 8-octahydro-1, 2, 8, 8-tetramethylnaphthalene
02/13/2008CN100368415C 6-alkenyl-, 6-alkinyl-and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
02/12/2008US7329654 Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
02/12/2008US7329634 pesticides and herbicides; dehalogenation and reduction of 3-[(2-ethyl-4-bromo-6-methyl)phenyl]-5,5-pentamethylenepyrrolidine-2,4-dione with halogenating agent in presence of solvent and free radical initiator; animal pests and crops controlling
02/07/2008WO2008015950A1 Acat inhibitor
02/07/2008US20080033072 Ink composition and inkjet ink, and image-forming method and recorded material using the same, and oxetane compound
02/06/2008CN101120002A Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
02/06/2008CN100367386C Optical information-recording medium, novel oxonol compound
02/06/2008CN100366623C Light-emitting device, condensed polycyclic compound used therein and method for producing same
02/06/2008CN100366605C Compounds to treat alzheimer's disease
02/06/2008CN100366144C Method for producing podophyllotoxin induced from sino podophyllum hexandrum callus
02/05/2008US7326798 Reacting 2-{[(S)-2-methylpent-4-in-1-yl]oxy}-3,4,5,6-tetrahydro-2H-pyrane with acetaldehyde to produce 2RS,6S)-6-Methyl-7-[(RS)-(3,4,5,6-tetrahydro-2H-pyran-2-yl)oxy]hept-3-in-2-ol
02/05/2008US7326796 Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography
02/05/2008CA2413515C Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them
01/2008
01/31/2008WO2008013834A1 Bisfuranyl protease inhibitors
01/31/2008WO2008013336A1 Pyripyropene derivatives and insecticidal compositions comprising them
01/31/2008WO2007103586A3 Process for the production of anhydrosugar alcohols
01/31/2008US20080027226 Electroluminescent Device
01/31/2008DE102006035035A1 Neue Materialien für organische Elektrolumineszenzvorrichtungen New materials for organic electroluminescent
01/31/2008CA2658545A1 Bisfuranyl protease inhibitors
01/29/2008US7323577 Such as reacting Bromine and of 2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran in sodium acetate and acetonitrile to produce 5-Bromo-2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran
01/29/2008CA2215682C 10-deacetylbaccatine iii and 10-deacetyl 14.beta.-hydroxybaccatine iii derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
01/24/2008WO2008010335A1 Plant extract having arthritis-preventive effect
01/24/2008WO2007140439A3 Compounds as cannabinoid receptor ligands and uses thereof
01/24/2008WO2007133597A9 Crystalline form of atorvastatin calcium stable after storage
01/24/2008WO2007103719A3 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
01/24/2008WO2007061874A3 Methods and compositions for use in treating cancer
01/24/2008WO2005030779A3 Laulimalide analogs with anti-cancer activitity
01/24/2008US20080021211 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies
01/24/2008US20080021093 Oxidation process with enhanced safety useful in the manufacture of Moxidectin
01/24/2008CA2657936A1 Antiviral protease inhibitors
01/24/2008CA2657821A1 Aza-peptide protease inhibitors
01/23/2008EP1879847A1 Terrylene and quaterrylene derivatives
01/23/2008EP1879687A2 Method for the surface treatment of a metallic or fibrous material
01/23/2008EP1879686A2 Method for the treatment of a material other than the human body
01/23/2008CN101108854A Separation purification process of cantharidin
01/23/2008CN101108853A Separation purification process of cantharidin
01/23/2008CN101108852A Novel technique for extracting and separating podophyllinic acid lactone
01/23/2008CN100363367C Compound with antitumor activity, and its preparing method and use
01/17/2008WO2008007629A1 Polyamic acid and polyimide
01/17/2008WO2008007132A1 Tetrahydrofuro [3, 2-b] pyrr0l-3-0ne intermediates
01/17/2008WO2007135294A3 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
01/17/2008WO2007089527A3 Method of forming a dianhydrosugar alcohol
01/17/2008WO2007089510A3 Methods for dehydration of sugars
01/17/2008US20080015365 reacting malonic acid with ketones such as methyl isobutyl ketone, 2-pentanone, cyclopentenone, cyclohexanone, adamantanone, cyclooctanone, ethyl levulinate, cyclohexane-1,4-dione, pinacolone or acetophenone, in solvents to form 1,3-dioxan-4,6-dione compounds, used as intermediates for drugs or pigments
01/17/2008CA2657797A1 Tetrahydrofuro [3, 2-b] pyrrol-3-one intermediates
01/16/2008CN101106986A Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
01/16/2008CN100362011C Preparation method of ginkgo leaf extract
01/15/2008CA2476004C A novel method for total synthesis of ciguatoxin ctx3c class
01/15/2008CA2132263C Liquid antioxidants as stabilisers
01/10/2008WO2008006025A1 Dihydrofuro pyrimidines as akt protein kinase inhibitors
01/10/2008WO2008004817A1 Novel decursin derivatives and the use thereof
01/10/2008WO2007135295A3 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same
01/10/2008WO2007026725A3 Drug, drug gudance system, magnetic detection system, and drug design method
01/10/2008US20080009531 5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes
01/10/2008US20080009450 Genipin derivatives and uses thereof
01/10/2008CA2656566A1 Dihydrofuro pyrimidines as akt protein kinase inhibitors
01/09/2008EP1875903A1 Tuberculosis treatment using pleuromutilin derivatives
01/09/2008CN101103011A Novel 2H-chromene derivatives as selective estrogen receptormodulators
01/09/2008CN101100470A Tetranuclear bipyrane coumarin compound
01/09/2008CN100360537C Fluorane kind derivant, its preparation and application
01/08/2008US7317113 Treatment of 7-Boc-13-keto-baccatin III to give 7-Boc-13-keto-14-hydroxy-baccatin III, carbonation of the 1 and 14 hydroxyls to give 14 beta -hydroxy-7-Boc-keto-baccatin III-1,14-carbonate, and reduction of the ketone at the 13-position and cleavage of the protective group
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 174